Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05330676 · ClinicalTrials.gov registry record
Evaluation of Microcirculatory Function and Mitochondrial Respiration After Cardiovascular Surgery
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 142
- Enrollment target
NCT05330676: Completed study, sponsored by University of Pennsylvania.
NCT05330676 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 142 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05330676 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 142 participants
- Enrollment target
Study Summary
This study will examine the differences in microcirculatory function and mitochondrial respiration in patients with shock after cardiovascular surgery.
Primary Outcome
Perfused vessel density (PVD) was measured with incident darkfield microscopy (units mm/mm\^2)
Interventions
- PROCEDURE coronary artery bypass grafting, valve repair/replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2023-04-01 |
What the finished NCT05330676 record still lists
NCT05330676 is an observational study that tracks outcomes without assigning an intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which coronary artery bypass grafting, valve repair/replacement is the first listed.
NCT05330676 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05330676 about?
NCT05330676 is a clinical study titled "Evaluation of Microcirculatory Function and Mitochondrial Respiration After Cardiovascular Surgery". This study will examine the differences in microcirculatory function and mitochondrial respiration in patients with shock after cardiovascular surgery.
What is the current status of trial NCT05330676?
This trial is currently completed. The enrollment target is 142 participants. The study started on 2020-09-01. Estimated completion is 2023-04-01.
What interventions are being tested in trial NCT05330676?
The interventions under investigation include: coronary artery bypass grafting, valve repair/replacement (PROCEDURE).
Who is sponsoring clinical trial NCT05330676?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI